🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 88032L605 (prev. 88032L100 )
- Market Cap
- Micro Cap
- Previous Symbol
- OXBT (changed 9/19/2014)
- Previous Name
- Oxygen Biotherapeutics, Inc.
Business: Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The company owns the North American rights to develop and commercialize levosimendan, and the United States Food and Drug Administration (FDA) has granted Fast Track status for levosimendan for the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome (LCOS).
Company Contact
- CEO
- Christopher Giordano
- CFO
- Lawrence Hoffman
- Headquarters
- 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC 27517
- Phone
- 919-855-2100
- Fax
- 919-855-2133
- Investor Relations
- Stephanie Carrington, Westwicke · 646-277-1282 · Stephanie.carrington@westwicke.com